Bill Miller - Miller Value Partners
Holding/activity history for Halozyme Therapeutics (HALO)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2020 Q1 | 0 | 0 | Sell 100.00% | 0.01 | |
| 2019 Q4 | 20,000 | 0.01 | $17.75 | ||
| 2019 Q3 | 20,000 | 0.01 | $15.50 | ||
| 2019 Q2 | 20,000 | 0.01 | $17.20 | ||
| 2019 Q1 | 20,000 | 0.01 | $16.10 | ||
| 2018 Q4 | 20,000 | 0.01 | Reduce 88.24% | 0.08 | $14.65 |
| 2018 Q3 | 170,000 | 0.10 | $18.17 | ||
| 2018 Q2 | 170,000 | 0.11 | $16.87 | ||
| 2018 Q1 | 170,000 | 0.15 | $19.59 | ||
| 2017 Q4 | 170,000 | 0.15 | $20.26 | ||
| 2017 Q3 | 170,000 | 0.14 | Reduce 82.10% | 0.64 | $17.37 |
| 2017 Q2 | 949,800 | 0.56 | Buy | 0.56 | $12.82 |